注册 登录 联系我们  
微创泌尿外科杂志  2019, Vol. 8 Issue (2): 104-107    DOI: 10.19558/j.cnki.10-1020/r.2019.02.007
  论著 本期目录 | 过刊浏览 | 高级检索 |
89例I型乳头状肾细胞癌的临床诊治分析
宣云东1, 顾良友1, 段珺耀1, 沈东来1, 李品1, 高宇1, 范阳1, 张旭1
1中国人民解放军总医院泌尿外科 中国人民解放军总医院肾脏疾病国家重点实验室 100853 北京
Clinical diagnosis and treatment of 89 patients with type 1 papillary renal cell carcinoma
XUAN Yundong1, GU Liangyou1, DUAN Junyao1, SHEN Donglai1, LI Pin1, GAO Yu1, FAN Yang1, ZHANG Xu1
1Department of Urology/State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100853, China
全文: PDF (705 KB)   RICH HTML
输出: BibTeX | EndNote (RIS)      
摘要 目的:研究Ⅰ型乳头状肾细胞癌的临床病理特征及预后,提高其临床诊疗水平。方法:回顾性分析2009年1月–2017年11月期间收治的89例经病理诊断为Ⅰ型乳头状肾细胞癌患者的临床及病理资料。其中男68例,女21例,年龄17~77岁,平均(50.0±13.5)岁。病变位于左侧者41例,右侧者48例。结果:89例患者均接受微创手术治疗。其中腹腔镜手术56例,机器人辅助腹腔镜手术33例,两组平均手术时间与平均术中出血量均差异无统计学意义。肿瘤最大径为0.8~13.0 cm,平均(4.5±2.4)cm。病理分期,73例pT1N0M0,9例pT2N0M0,6例pT3N0M0,1例pT1N0M1。术后所有病例均获随访,随访时间4~90个月,平均30.6个月,6例发生转移,2例因转移死亡。结论:Ⅰ型乳头状肾细胞癌是一类发病率较低的肾细胞癌。外科手术是目前首选的治疗方式,机器人手术与腹腔镜手术治疗效果相似。本病较少存在复发和转移,预后良好。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
宣云东
顾良友
段珺耀
沈东来
李品
高宇
范阳
张旭
关键词 肾细胞癌肾乳头状细胞癌诊断治疗预后    
AbstractObjective: To improve the diagnosis and treatment of type 1 papillary renal cell carcinoma (PRCC) by exploring the clinical features of PRCC patients in our hospital. Method: We retrospectively reviewed the clinicopathologic data of 89 patients with PRCC admitted at our hospital from January 2009 to November 2017. The mean age of these patients at diagnosis was 50 years including 68 males and 21 females. All tumors were localized unilaterally with 41 in left kidney and 48 in right kidney. Result: All of the 89 patients were given mini-invasive surgery nephrectomy successfully. Fifty-six patients received laparoscopic surgery and the rest were treated with robot-assisted laparoscopic surgery. The mean operative time and the mean operative blood loss between two groups showed no significant difference. The average maximum diameter of tumors was 4.5 cm. Among them, 73 patients were at pT1N0M0, 9 at pT2N0M0, 6 at pT3N0M0 and 1 at pT1N0M1. All patients were followed up with a mean duration of 30.6 months. Metastases occurred in 6 cases, and 2 died eventually. Conclusions: Type 1 PRCC is a rare subtype of renal cell carcinoma with infrequent recurrence and metastasis. Surgery is the standard treatment. The laparoscopic surgery has similar treatment efficacy to robot-assisted laparoscopic surgery. Type 1 PRCC patients have favorable prognosis.
Key wordsrenal cell carcinoma    papillary renal cell carcinoma    diagnosis    treatment    prognosis
收稿日期: 2018-12-24     
ZTFLH:  R737.11  
通讯作者: 张旭,xzhang@foxmail.com   
引用本文:   
宣云东, 顾良友, 段珺耀, 沈东来, 李品, 高宇, 范阳, 张旭. 89例I型乳头状肾细胞癌的临床诊治分析[J]. 微创泌尿外科杂志, 2019, 8(2): 104-107.
XUAN Yundong, GU Liangyou, DUAN Junyao, SHEN Donglai, LI Pin, GAO Yu, FAN Yang, ZHANG Xu. Clinical diagnosis and treatment of 89 patients with type 1 papillary renal cell carcinoma. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2019, 8(2): 104-107.
链接本文:  
http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/abstract/abstract1490.shtml     或     http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/Y2019/V8/I2/104
京ICP备14007602 版权所有 © 微创泌尿外科杂志 地址:北京市复兴路28号 邮编:100853
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn